The Role of Pharmacogenomics in Addressing Racial and Ethnic Health Disparities
Despite the rapid evolution of genetic technologies, the integration of genomic insights to alleviate health disparities in…
-
-
Assessment of the Clinical Validity of Pharmacogenomics in Pain Management.
The Institute of Medicine reveals that one-third of the U.S. population grapples with persistent pain, underscoring a…
-
Lessons from COVID-19: Pharmacogenomics in Preparing for Future Pandemics
The COVID-19 pandemic has posed unprecedented challenges, prompting a critical inquiry: Might our genetic makeup hold the…
-
What is “Omics” and is Pharmacogenomics a Part of It?
In the realm of medical research, a novel domain has surfaced – “omics.” It encompasses the in-depth…
-
PGx and the Microbiome: Understanding How Gut Bacteria Influence Drug Response
Explore the synergy between PGx and the Microbiome to unlock the secrets of gut health’s role in shaping personalized drug responses.
-
PGx-Guided Antiplatelet Therapy: Reducing Bleeding Risks with Personalized Dosing
Unlock personalized dosing for safer antiplatelet therapy with pharmacogenomics, reducing bleeding risks in cardiovascular care.
-
Many Drug Resistance Genes When Detected Have no Effect on the Phenotype
Explore the complexities of drug resistance genes and their variable impact on phenotypes in our deep dive into genetic influences on treatment outcomes.
-
PGx Testing: A Game Changer for Drug Development and Clinical Trials
Unlock personalized medicine with PGx Testing – revolutionizing drug development and optimizing clinical trials for tailored treatments.
-
The Rise of Polygenic Risk Scores: Can PGx Predict Susceptibility to Medication Side Effects?
Explore how Polygenic Risk Scores enhance personalized medicine by predicting medication side effects and disease susceptibility.
-
CYP2B6 Can Affect How Several Antidepressants are Metabolized
Discover how the CYP2B6 enzyme influences the metabolism of various antidepressants, affecting drug efficacy and interactions.
-
The Importance of Non-Molecular Based Pharmacogenomics Testing
Explore the benefits of Non-Molecular Based Pharmacogenomics Testing for tailored drug therapy that aligns with your unique genetic profile.
-
Which is a Better Lab Test, PCR or Culture?
Explore the distinctions between PCR or culture to determine the superior lab testing method for accurate diagnostics and treatment.
-
The World of Genomic Mutations
Explore the intricate realm of Genomic Mutations, their impacts on health, and advances in detection and management strategies.
-
Navigating the Complexity of Payors for PGx Testing
Uncover how payors for PGx testing are shaping access to precision medicine and influencing insurance coverage for personalized healthcare.
-
The Lifeline of PGx and Factor V Leiden
Explore how PGx and Factor V Leiden intertwine to influence medication efficacy and safety for those with genetic clotting disorders.
-
PGx Patients Facing Resistance from Providers Due to an Educational Gap
Discover why PGx patients facing resistance and the importance of bridging the educational gap in precision medicine for enhanced patient care.
-
Proper Chain of Custody for Genetic Testing Results to Avoid Conflict of Interest
Ensure the integrity of genetic tests with proper chain of custody for genetic testing results, safeguarding data and maintaining trust.
-
Predict High Sensitivity to Warfarin Through CYP2C9
Discover how CYP2C9 genetic variations impact warfarin sensitivity and can guide personalized anticoagulant therapy for better patient outcomes.
-
The Need for a Standardized Approach When Interpreting PGx Results
Explore the importance of a standardized approach in interpreting PGx results for effective personalized medicine guidance.
-
What is the Significance of Non-Metabolizing Genes and Why they Should be PGx Tested
Understand the crucial role of non-metabolizing genes and why they should be PGx tested and payor covered.
